Jessica C. Mackinnon-Johnson
Sydney, NSW, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
A laboratory framework for ongoing optimization of amplification-based genomic surveillance programs.
Journal: Microbiology spectrum
Published: November 15, 2023
Improved Neutralisation of the SARS-CoV-2 Omicron Variant following a Booster Dose of Pfizer-BioNTech (BNT162b2) COVID-19 Vaccine.
Journal: Viruses
Published: August 08, 2022
Resistance Mutations in SARS-CoV-2 Delta Variant after Sotrovimab Use.
Journal: The New England journal of medicine
Published: March 09, 2022
Co-infection with SARS-CoV-2 Omicron and Delta variants revealed by genomic surveillance.
Journal: Nature communications
Published: February 08, 2022
SARS-CoV-2 Within-Host and in vitro Genomic Variability and Sub-Genomic RNA Levels Indicate Differences in Viral Expression Between Clinical Cohorts and in vitro Culture.
Journal: Frontiers in microbiology
Published: November 29, 2021
SARS-CoV-2 Genome Sequencing Methods Differ in Their Abilities To Detect Variants from Low-Viral-Load Samples.
Journal: Journal of clinical microbiology
Published: August 11, 2021
Multilocus Sequence Typing (MLST) and Random Polymorphic DNA (RAPD) Comparisons of Geographic Isolates of Neoparamoeba perurans, the Causative Agent of Amoebic Gill Disease.
Journal: Pathogens (Basel, Switzerland)
Published: September 01, 2019
Genome sequencing reveals metabolic and cellular interdependence in an amoeba-kinetoplastid symbiosis.
Journal: Scientific reports
Published: March 23, 2017
Showing 1-8 of 8
Last Updated: 09/26/2026